INmune Bio Inc
INMB
$1.89+3.28%
End of day · as of Oct 9, 2026, 6:46 PM ET
Mkt cap
$33.50M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$50,000
EPS (H1 2026)
$-0.25
Gross Margin (qtr ended 2025-09-30)
N/A
Profit Margin (qtr ended 2025-09-30)
-12944.00%
Beta
1.01
Div yield
N/A
Sector
Healthcare
INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Use this INMB research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full INMB income, balance, and cash tables.
INmune Bio Inc (INMB) is a biotechnology company in the Healthcare sector.
Latest cached INmune Bio Inc (INMB) revenue for Sep 30, 2025 was $50.0K. Net income was -$6.5M. Statements: https://lician.com/financials/inmb
INmune Bio Inc (INMB) market capitalization is $33.5M on the latest cached snapshot.
INmune Bio Inc (INMB) cached previous close $1.83; day range $1.84 – $1.91; volume 91,630. Session quote: https://lician.com/quote/inmb
INmune Bio Inc (INMB) latest cached earnings event is "INMB earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached INMB filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/inmb